Wockhardt Current Share Price | Wockhardt Stock Screener
WOCKPHARMA
Pharmaceuticals
Wockhardt Current Stock Price Today
Live Share Price NSE
₹2086.10
▲
13.80 (0.67%)
Live Share Price BSE
₹2086.95
▲
16.15 (0.78%)
As of September 18, 2026, the live Wockhardt share price (NSE: WOCKPHARMA) is ₹2,086.10 on NSE and ₹2,086.95 on BSE, up 0.67% from the previous close, with shares trading between ₹2,047.30 and ₹2,109.30 in today's trading session, and a 52-week range of ₹1,100.30–₹2,248.80.
Browse WOCKPHARMA cash flow statement to support your investment research.
Use the Wockhardt stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Wockhardt Market Cap
₹35,413.54 Cr.
WOCKPHARMA P/E Ratio (TTM)
87.12
Wockhardt P/B Ratio
7.30
EPS (TTM)
₹13.12
Dividend Yield
-
Debt to Equity
0.46
WOCKPHARMA 52 Week High
₹2248.80
Wockhardt 52 Week Low
₹1100.30
Operating Margin
21.00%
Profit Margin
11.15%
WOCKPHARMA Revenue (TTM)
₹960.00
EBITDA
₹223.00
Net Income
₹107.00
Total Assets
₹8,615.00
Total Equity
₹5,281.00
Wockhardt Current Share Price Chart
Track the current Wockhardt share price and stock price with an interactive chart. Analyse WOCKPHARMA price trends, trading volume, historical performance, and volatility across different timeframes — the complete Wockhardt stock quote in one place.
Wockhardt Company Profile - Fundamental Screener
Screen Wockhardt company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for WOCKPHARMA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE049B01025
Wockhardt Balance Sheet Screener
Screen WOCKPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 8,615 | 8,135 | 7,649 | 7,683 | 8,243 | 7,774 | 8,179 | 7,844 | 8,162 | 9,022 |
| Current Assets | 2,606 | 2,465 | 2,073 | 2,208 | 2,589 | 2,425 | 2,430 | 2,815 | 3,380 | 4,535 |
| Fixed Assets | 2,791 | 2,736 | 2,881 | 3,042 | 3,462 | 3,343 | 3,502 | 3,058 | 2,888 | 2,773 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1,712 | 1,436 | 1,196 | 586 | 834 | 894 | 1,624 | 1,976 | 2,272 | 3,324 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 5,281 | 4,657 | 3,662 | 3,662 | 4,202 | 3,759 | 3,058 | 3,005 | 3,198 | 3,719 |
| Share Capital | 81 | 81 | 77 | 72 | 72 | 55 | 55 | 55 | 55 | 55 |
| Reserves & Surplus | 4,859 | 4,272 | 3,282 | 3,282 | 3,777 | 3,321 | 2,616 | 2,620 | 2,797 | 3,281 |
Wockhardt Income Statement Screener - Profit & Revenue Analysis
Screen Wockhardt income statement and profit fundamentals.
Analyze WOCKPHARMA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Wockhardt share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 960 | 1,032 | 913 | 803 | 758 | 758 | 729 | 818 | 769 | 754 | 709 | 777 | 658 | 710 | 701 |
| Expenses | 737 | 740 | 721 | 604 | 763 | 679 | 593 | 699 | 648 | 803 | 664 | 681 | 642 | 771 | 657 |
| EBITDA | 223 | 292 | 192 | 199 | -5 | 79 | 136 | 119 | 121 | -49 | 45 | 96 | 16 | -61 | 44 |
| Operating Profit % | 21.00% | 23.00% | 19.00% | 23.00% | -3.00% | 9.00% | 18.00% | 14.00% | 12.00% | -15.00% | 5.00% | 10.00% | 0.00% | -14.00% | 6.00% |
| Depreciation | 55 | 53 | 65 | 53 | 56 | 53 | 55 | 55 | 54 | 58 | 55 | 55 | 55 | 56 | 66 |
| Interest | 52 | 50 | 60 | 55 | 48 | 48 | 60 | 73 | 73 | 73 | 77 | 76 | 79 | 76 | 83 |
| Profit Before Tax | 116 | 189 | 67 | 91 | -109 | -22 | 21 | -9 | -6 | -180 | -87 | -35 | -118 | -193 | -105 |
| Tax | 9 | 25 | 6 | 9 | -1 | 23 | 1 | 7 | 10 | -3 | -1 | 38 | 18 | 44 | -3 |
| Net Profit | 107 | 164 | 61 | 82 | -108 | -45 | 20 | -16 | -16 | -177 | -86 | -73 | -136 | -237 | -102 |
| EPS | 6.55 | 10.23 | 3.61 | 4.81 | -5.53 | -1.57 | 0.91 | -1.47 | -0.95 | -11.64 | -5.75 | -5.37 | -9.28 | -14.37 | -6.62 |
Wockhardt Cash Flow Screener - Liquidity Fundamentals
Screen WOCKPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 390 | -22 | 219 | 153 | 413 | -287 | 649 | 183 | 68 | -270 |
| Investing Activities | -231 | -780 | -138 | -118 | -204 | 1,471 | -147 | 93 | 635 | -684 |
| Financing Activities | -54 | 409 | 334 | -315 | -71 | -1,171 | -680 | -777 | -770 | 1,255 |
| Net Cash Flow | 105 | -393 | 415 | -280 | 138 | 13 | -178 | -500 | -66 | 301 |
Wockhardt Shareholding Pattern Screener
See Wockhardt shareholding pattern with promoter, FII, and DII holdings.
Check Wockhardt promoter holding and ownership changes for WOCKPHARMA on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Nov |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 49.08% | 49.08% | 49.08% | 49.08% | 49.09% | 49.09% | 49.09% | 49.09% |
| FII Holding | 7.22% | 7.09% | 6.99% | 7.10% | 7.29% | 6.81% | 6.54% | 6.62% |
| DII Holding | 9.24% | 10.96% | 10.55% | 11.01% | 11.01% | 10.59% | 9.82% | 9.88% |
| Govt Holding | 0.02% | 0.04% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| Public Holding | 27.31% | 25.89% | 26.52% | 26.10% | 26.05% | 26.69% | 27.49% | 27.45% |
| Other Holding | 7.13% | 6.94% | 6.84% | 6.69% | 6.55% | 6.80% | 7.04% | 6.95% |
| Shareholder Count | 166,518 | 139,016 | 142,274 | 137,946 | 146,918 | 141,799 | 142,710 | 143,876 |
Wockhardt Share Dividend Screener - Share Yield Analysis
Check Wockhardt dividend history with payout and yield data.
View Wockhardt dividend details including ex-dates and amounts for WOCKPHARMA stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹10.00 | 1.49% |
Wockhardt Stock Index Membership
See which indices include Wockhardt stock.
Check WOCKPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY 500
NIFTY MIDSML 400
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 MULTICAP
Wockhardt Market Events Screener - Corporate Actions
Get Wockhardt corporate actions including splits, bonuses, and buybacks.
Check Wockhardt stock events that may affect WOCKPHARMA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-10 | 2026-08-10 | Quarterly Result Announcement | NA | -0.36% |
| 2026-08-10 | 2026-08-10 | Annual General Meeting | NA | 3.64% |
| 2026-05-04 | 2026-05-04 | Quarterly Result Announcement | NA | -3.14% |
| 2026-02-10 | 2026-02-10 | Quarterly Result Announcement | NA | 4.57% |
| 2025-11-03 | 2025-11-03 | Quarterly Result Announcement | NA | -1.20% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -8.71% |
| 2025-08-08 | 2025-08-08 | Annual General Meeting | NA | -16.82% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 1.49% |
| 2025-02-07 | 2025-02-07 | Quarterly Result Announcement | NA | 5.96% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -2.06% |
| 2024-06-28 | 2024-06-28 | Annual General Meeting | NA | 27.23% |
| 2022-03-08 | 2022-03-09 | Rights | 3:10 | -1.19% |
Wockhardt Competitors Screener - Peer Comparison
Screen WOCKPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 441,478 | 36.91 | 61,674 | 12.69% | 11,565 | 34.00 |
| Divis Laboratories | 247,470 | 85.36 | 11,067 | 13.95% | 2,568 | 63.65 |
| Torrent Pharmaceuticals | 188,872 | 86.95 | 13,886 | 20.34% | 2,138 | 52.16 |
| Zydus Life Science | 112,608 | 24.28 | 27,658 | 17.64% | 5,026 | 45.64 |
| Cipla | 110,352 | 33.22 | 29,045 | 2.24% | 3,870 | 35.27 |
| Laurus Labs | 106,298 | 95.94 | 6,868 | 22.01% | 890 | 68.28 |
| Dr Reddys Laboratories | 97,281 | 29.91 | 35,059 | 3.90% | 4,158 | 47.72 |
| Aurobindo Pharma | 96,652 | 25.88 | 34,145 | 5.56% | 3,503 | 57.04 |
| Lupin | 95,790 | 17.09 | 29,039 | 26.75% | 5,356 | 28.17 |
| Mankind Pharma | 94,163 | 44.87 | 14,636 | 14.85% | 1,938 | 37.57 |
Wockhardt Company Announcements - News Screener
Screen WOCKPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-25 | Disclosure under Regulation 30A of LODR | - |
| 2026-08-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-10 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-10 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-10 | Financial Results For The Quarter Ended 30Th June 2026 | - |
| 2026-08-10 | Board Meeting Outcome for Outcome Of The Board Meeting | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-05 | Addendum To The Notice Of 27Th Annual General Meeting Of The Company | - |
| 2026-08-04 | Board Meeting Intimation for Approval Of The Un-Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June 2026. | - |
| 2026-07-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-17 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-07-17 | Reg. 34 (1) Annual Report. | - |
| 2026-07-17 | Notice Of 27Th Annual General Meeting And The Annual Report Of The Company For The Financial Year 2025-26. | - |
| 2026-07-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-25 | Closure of Trading Window | - |